A citation-based method for searching scientific literature

Hyo Sup Shim, Mari- Kenudson, Zongli Zheng, Matthew Liebers, Yoon Jin Cha, Quan Hoang Ho, Maristela Onozato, Long Phi Le, Rebecca S Heist, A John Iafrate. J Thorac Oncol 2015
Times Cited: 95







List of co-cited articles
623 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma.
William D Travis, Elisabeth Brambilla, Masayuki Noguchi, Andrew G Nicholson, Kim R Geisinger, Yasushi Yatabe, David G Beer, Charles A Powell, Gregory J Riely, Paul E Van Schil,[...]. J Thorac Oncol 2011
40

Druggable oncogene fusions in invasive mucinous lung adenocarcinoma.
Takashi Nakaoku, Koji Tsuta, Hitoshi Ichikawa, Kouya Shiraishi, Hiromi Sakamoto, Masato Enari, Koh Furuta, Yoko Shimada, Hideaki Ogiwara, Shun-ichi Watanabe,[...]. Clin Cancer Res 2014
124
37

CD74-NRG1 fusions in lung adenocarcinoma.
Lynnette Fernandez-Cuesta, Dennis Plenker, Hirotaka Osada, Ruping Sun, Roopika Menon, Frauke Leenders, Sandra Ortiz-Cuaran, Martin Peifer, Marc Bos, Juliane Daßler,[...]. Cancer Discov 2014
163
29

Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases.
Akihiko Yoshizawa, Noriko Motoi, Gregory J Riely, Cami S Sima, William L Gerald, Mark G Kris, Bernard J Park, Valerie W Rusch, William D Travis. Mod Pathol 2011
668
29

Prognosis in Resected Invasive Mucinous Adenocarcinomas of the Lung: Related Factors and Comparison with Resected Nonmucinous Adenocarcinomas.
Ho Yun Lee, Min Jae Cha, Kyung Soo Lee, Hee Young Lee, O Jung Kwon, Joon Young Choi, Hong Kwan Kim, Yong Soo Choi, Jhingook Kim, Young Mog Shim. J Thorac Oncol 2016
38
71

Associations between mutations and histologic patterns of mucin in lung adenocarcinoma: invasive mucinous pattern and extracellular mucin are associated with KRAS mutation.
Kyuichi Kadota, Yi-Chen Yeh, Sandra P D'Angelo, Andre L Moreira, Deborah Kuk, Camelia S Sima, Gregory J Riely, Maria E Arcila, Mark G Kris, Valerie W Rusch,[...]. Am J Surg Pathol 2014
104
27

KRAS and NKX2-1 Mutations in Invasive Mucinous Adenocarcinoma of the Lung.
David H Hwang, Lynette M Sholl, Vanesa Rojas-Rudilla, Dimity L Hall, Priyanka Shivdasani, Elizabeth P Garcia, Laura E MacConaill, Marina Vivero, Jason L Hornick, Frank C Kuo,[...]. J Thorac Oncol 2016
44
47

The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification.
William D Travis, Elisabeth Brambilla, Andrew G Nicholson, Yasushi Yatabe, John H M Austin, Mary Beth Beasley, Lucian R Chirieac, Sanja Dacic, Edwina Duhig, Douglas B Flieder,[...]. J Thorac Oncol 2015
21


Mucinous differentiation correlates with absence of EGFR mutation and presence of KRAS mutation in lung adenocarcinomas with bronchioloalveolar features.
Karin E Finberg, Lecia V Sequist, Victoria A Joshi, Alona Muzikansky, Julie M Miller, Moonjoo Han, Javad Beheshti, Lucian R Chirieac, Eugene J Mark, A John Iafrate. J Mol Diagn 2007
153
18

The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival.
Arne Warth, Thomas Muley, Michael Meister, Albrecht Stenzinger, Michael Thomas, Peter Schirmacher, Philipp A Schnabel, Jan Budczies, Hans Hoffmann, Wilko Weichert. J Clin Oncol 2012
462
18

Clinical course of stage IV invasive mucinous adenocarcinoma of the lung.
Yoon Jin Cha, Hye Ryun Kim, Hye-Jeong Lee, Byoung Chul Cho, Hyo Sup Shim. Lung Cancer 2016
25
72

Biology of invasive mucinous adenocarcinoma of the lung.
Yoon Jin Cha, Hyo Sup Shim. Transl Lung Cancer Res 2017
31
58

Distinct clinicopathologic characteristics of lung mucinous adenocarcinoma with KRAS mutation.
Hideomi Ichinokawa, Genichiro Ishii, Kanji Nagai, Akikazu Kawase, Junji Yoshida, Mitsuyo Nishimura, Tomoyuki Hishida, Naomi Ogasawara, Katsuya Tsuchihara, Atsushi Ochiai. Hum Pathol 2013
25
68

Validation of the IASLC/ATS/ERS lung adenocarcinoma classification for prognosis and association with EGFR and KRAS gene mutations: analysis of 440 Japanese patients.
Akihiko Yoshizawa, Shinji Sumiyoshi, Makoto Sonobe, Masashi Kobayashi, Masakazu Fujimoto, Fumi Kawakami, Tatsuaki Tsuruyama, William D Travis, Hiroshi Date, Hironori Haga. J Thorac Oncol 2013
301
17

A single institution-based retrospective study of surgically treated bronchioloalveolar adenocarcinoma of the lung: clinicopathologic analysis, molecular features, and possible pitfalls in routine practice.
Christian Casali, Giulio Rossi, Alessandro Marchioni, Giuliana Sartori, Federica Maselli, Lucia Longo, Emilia Tallarico, Uliano Morandi. J Thorac Oncol 2010
55
23

Relation between thin-section computed tomography and clinical findings of mucinous adenocarcinoma.
Hajime Watanabe, Haruhiro Saito, Tomoyuki Yokose, Yuji Sakuma, Shuji Murakami, Tetsuro Kondo, Fumihiro Oshita, Hiroyuki Ito, Haruhiko Nakayama, Kouzo Yamada,[...]. Ann Thorac Surg 2015
30
40

Pulmonary invasive mucinous adenocarcinoma and mixed invasive mucinous/nonmucinous adenocarcinoma-a clinicopathological and molecular genetic study with survival analysis.
Jennifer M Boland, Joseph J Maleszewski, Jason A Wampfler, Jesse S Voss, Benjamin R Kipp, Ping Yang, Eunhee S Yi. Hum Pathol 2018
28
42

Nkx2-1 represses a latent gastric differentiation program in lung adenocarcinoma.
Eric L Snyder, Hideo Watanabe, Margaret Magendantz, Sebastian Hoersch, Tiffany A Chen, Diana G Wang, Denise Crowley, Charles A Whittaker, Matthew Meyerson, Shioko Kimura,[...]. Mol Cell 2013
137
11

NRG1 fusion in a French cohort of invasive mucinous lung adenocarcinoma.
Michaël Duruisseaux, Anne McLeer-Florin, Martine Antoine, Sanaz Alavizadeh, Virginie Poulot, Roger Lacave, Nathalie Rabbe, Jacques Cadranel, Marie Wislez. Cancer Med 2016
24
45

Gene signature driving invasive mucinous adenocarcinoma of the lung.
Minzhe Guo, Koichi Tomoshige, Michael Meister, Thomas Muley, Takuya Fukazawa, Tomoshi Tsuchiya, Rebekah Karns, Arne Warth, Iris M Fink-Baldauf, Takeshi Nagayasu,[...]. EMBO Mol Med 2017
52
21

Response to ERBB3-Directed Targeted Therapy in NRG1-Rearranged Cancers.
Alexander Drilon, Romel Somwar, Biju P Mangatt, Henrik Edgren, Patrice Desmeules, Anja Ruusulehto, Roger S Smith, Lukas Delasos, Morana Vojnic, Andrew J Plodkowski,[...]. Cancer Discov 2018
87
12

Comparison of clinical features, molecular alterations, and prognosis in morphological subgroups of lung invasive mucinous adenocarcinoma.
Deng Cai, Hang Li, Rui Wang, Yuan Li, Yunjian Pan, Haichuan Hu, Yang Zhang, Ranxia Gong, Bin Pan, Yihua Sun,[...]. Onco Targets Ther 2014
18
55


Kras(G12D) and Nkx2-1 haploinsufficiency induce mucinous adenocarcinoma of the lung.
Yutaka Maeda, Tomoshi Tsuchiya, Haiping Hao, David H Tompkins, Yan Xu, Michael L Mucenski, Lingling Du, Angela R Keiser, Takuya Fukazawa, Yoshio Naomoto,[...]. J Clin Invest 2012
104
10

The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer.
Peter Goldstraw, Kari Chansky, John Crowley, Ramon Rami-Porta, Hisao Asamura, Wilfried E E Eberhardt, Andrew G Nicholson, Patti Groome, Alan Mitchell, Vanessa Bolejack. J Thorac Oncol 2016
10

Tumor Spread through Air Spaces is an Important Pattern of Invasion and Impacts the Frequency and Location of Recurrences after Limited Resection for Small Stage I Lung Adenocarcinomas.
Kyuichi Kadota, Jun-Ichi Nitadori, Camelia S Sima, Hideki Ujiie, Nabil P Rizk, David R Jones, Prasad S Adusumilli, William D Travis. J Thorac Oncol 2015
278
10

Oncogenic function and clinical implications of SLC3A2-NRG1 fusion in invasive mucinous adenocarcinoma of the lung.
Dong Hoon Shin, Donghoon Lee, Dong Wan Hong, Seung Hyun Hong, Jung-Ah Hwang, Byung Il Lee, Hye Jin You, Geon Kook Lee, In-Hoo Kim, Yeon-Su Lee,[...]. Oncotarget 2016
43
23

Clinicopathological and immunohistochemical features of lung invasive mucinous adenocarcinoma based on computed tomography findings.
Katsuhiko Shimizu, Riki Okita, Shinsuke Saisho, Ai Maeda, Yuji Nojima, Masao Nakata. Onco Targets Ther 2016
18
55

Non-mucinous and mucinous subtypes of adenocarcinoma with bronchioloalveolar carcinoma features differ by biomarker expression and in the response to gefitinib.
Marie Wislez, Martine Antoine, Laurence Baudrin, Virginie Poulot, Agnes Neuville, Maryvonne Pradere, Elisabeth Longchampt, Sylvie Isaac-Sibille, Marie-Paule Lebitasy, Jacques Cadranel. Lung Cancer 2010
66
13

Frequency of EGFR and KRAS mutations in Japanese patients with lung adenocarcinoma with features of the mucinous subtype of bronchioloalveolar carcinoma.
Akito Hata, Nobuyuki Katakami, Shiro Fujita, Reiko Kaji, Yukihiro Imai, Yutaka Takahashi, Takashi Nishimura, Keisuke Tomii, Kyosuke Ishihara. J Thorac Oncol 2010
52
17

Molecular Pathways: Targeting NRG1 Fusions in Lung Cancer.
Lynnette Fernandez-Cuesta, Roman K Thomas. Clin Cancer Res 2015
43
20

Transcriptome meta-analysis of lung cancer reveals recurrent aberrations in NRG1 and Hippo pathway genes.
Saravana M Dhanasekaran, O Alejandro Balbin, Guoan Chen, Ernest Nadal, Shanker Kalyana-Sundaram, Jincheng Pan, Brendan Veeneman, Xuhong Cao, Rohit Malik, Pankaj Vats,[...]. Nat Commun 2014
103
9

Durable Response to Afatinib in Lung Adenocarcinoma Harboring NRG1 Gene Fusions.
Nathan D Gay, Ying Wang, Carol Beadling, Andrea Warrick, Tanaya Neff, Christopher L Corless, Khaled Tolba. J Thorac Oncol 2017
40
22

HNF4α as a marker for invasive mucinous adenocarcinoma of the lung.
Masato Sugano, Toru Nagasaka, Eiichi Sasaki, Yoshiko Murakami, Waki Hosoda, Toyoaki Hida, Tetsuya Mitsudomi, Yasushi Yatabe. Am J Surg Pathol 2013
54
14

VAMP2-NRG1 Fusion Gene is a Novel Oncogenic Driver of Non-Small-Cell Lung Adenocarcinoma.
Yeonjoo Jung, Seunghui Yong, Pora Kim, Hee-Young Lee, Yeonhwa Jung, Juhee Keum, Sanghyuk Lee, Jhingook Kim, Jaesang Kim. J Thorac Oncol 2015
23
34

Clinicopathological features of lung adenocarcinoma with KRAS mutations.
Seiichi Kakegawa, Kimihiro Shimizu, Masayuki Sugano, Yohei Miyamae, Kyoichi Kaira, Takuya Araki, Tetsuhiro Nakano, Mitsuhiro Kamiyoshihara, Osamu Kawashima, Izumi Takeyoshi. Cancer 2011
48
16

Analysis of the clinicopathologic characteristics and prognostic of stage I invasive mucinous adenocarcinoma.
Jizhuang Luo, Rui Wang, Baohui Han, Jie Zhang, Heng Zhao, Wentao Fang, Qingquan Luo, Jun Yang, Yunhai Yang, Lei Zhu,[...]. J Cancer Res Clin Oncol 2016
16
50

Pulmonary mucinous adenocarcinomas: architectural patterns in correlation with genetic changes, prognosis and survival.
Abidin Geles, Ulrike Gruber-Moesenbacher, Franz Quehenberger, Claudia Manzl, Mohamed Al Effah, Elisabeth Grygar, Freyja Juettner-Smolle, Helmut H Popper. Virchows Arch 2015
18
44

Retrospective Multicenter Study Investigating the Role of Targeted Next-Generation Sequencing of Selected Cancer Genes in Mucinous Adenocarcinoma of the Lung.
Luisella Righi, Simona Vatrano, Federica Di Nicolantonio, Federica Massa, Giulio Rossi, Alberto Cavazza, Marco Volante, Arianna Votta, Stefania Izzo, Marco Lo Iacono,[...]. J Thorac Oncol 2016
14
57

Frequent NRG1 fusions in Caucasian pulmonary mucinous adenocarcinoma predicted by Phospho-ErbB3 expression.
Domenico Trombetta, Paolo Graziano, Aldo Scarpa, Angelo Sparaneo, Giulio Rossi, Antonio Rossi, Massimo Di Maio, Davide Antonello, Andrea Mafficini, Federico Pio Fabrizio,[...]. Oncotarget 2018
26
30

Successful targeting of the NRG1 pathway indicates novel treatment strategy for metastatic cancer.
M R Jones, H Lim, Y Shen, E Pleasance, C Ch'ng, C Reisle, S Leelakumari, C Zhao, S Yip, J Ho,[...]. Ann Oncol 2017
58
13


Detection of NRG1 Gene Fusions in Solid Tumors.
Sushma Jonna, Rebecca A Feldman, Jeffrey Swensen, Zoran Gatalica, Wolfgang M Korn, Hossein Borghaei, Patrick C Ma, Jorge J Nieva, Alexander I Spira, Ari M Vanderwalde,[...]. Clin Cancer Res 2019
78
10


Co-occurring genomic alterations define major subsets of KRAS-mutant lung adenocarcinoma with distinct biology, immune profiles, and therapeutic vulnerabilities.
Ferdinandos Skoulidis, Lauren A Byers, Lixia Diao, Vassiliki A Papadimitrakopoulou, Pan Tong, Julie Izzo, Carmen Behrens, Humam Kadara, Edwin R Parra, Jaime Rodriguez Canales,[...]. Cancer Discov 2015
448
7


New IASLC/ATS/ERS classification and invasive tumor size are predictive of disease recurrence in stage I lung adenocarcinoma.
Naoki Yanagawa, Satoshi Shiono, Masami Abiko, Shin-ya Ogata, Toru Sato, Gen Tamura. J Thorac Oncol 2013
103
7

Prognostic significance of adenocarcinoma in situ, minimally invasive adenocarcinoma, and nonmucinous lepidic predominant invasive adenocarcinoma of the lung in patients with stage I disease.
Kyuichi Kadota, Jonathan Villena-Vargas, Akihiko Yoshizawa, Noriko Motoi, Camelia S Sima, Gregory J Riely, Valerie W Rusch, Prasad S Adusumilli, William D Travis. Am J Surg Pathol 2014
161
7

Anchored multiplex PCR for targeted next-generation sequencing.
Zongli Zheng, Matthew Liebers, Boryana Zhelyazkova, Yi Cao, Divya Panditi, Kerry D Lynch, Juxiang Chen, Hayley E Robinson, Hyo Sup Shim, Juliann Chmielecki,[...]. Nat Med 2014
514
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.